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ABSTRACT 
Blastocystis hominis is a protozoan intestinal parasite and it has a  widespread geographic distribution in countries of all income levels globally. A true 
pathogenic  status  of  Blastocystis  hominis  is  yet  controversial;  while  it  has  been  found  in  patients  with  gastrointestinal  symptoms  mainly.  Moreover, 
Blastocystis is usually found in people who report no symptoms, and it has been estimated that most cases may be asymptomatic. The plausible reasons could 
be Blastocystis’ lack of pathogenicity or personal immunity of the host. Research on Blastocystis hominis is scarce with large gaps remaining in complete 
understanding. In this regard, this review highlights its life cycle, transmission mechanisms, incubation period, epidemiology, and treatment options.  
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INTRODUCTION 
History of Blastocystis: 
Blastocystis spp. is the anaerobic, cosmopolitan, eukaryotic, 
and enteric protozoan inhibits the intestinal tract of human1. 
Blastocystis  revealed  by  a  Russian  physician,  Fedor 
Aleksandrovich Lesh in 18702. Brumpt was chosen the name 
Blastocystis hominis in 19123.  
Classification of Blastocystis:  
Blastocystis  has  been  established  in  birds,  wild  boars, 
domestic  pigs,  rodents,  horses,  amphibians,  reptiles  and 
insects4. Blastocystis spp. from different non-human hosts are 
morphologically identical to B. hominis; and these different 
isolates  from  different  hosts  have  been  reported  as 
Blastocystis spp5,6.  According to recent classification Class: 
Blastocystiea,  Subphylum:  Obalinata,  infra  Kingdom: 
Heterkonda,  subkingdom:  Chromotopia,  and  Kingdom: 
Chromista7. 
Morphology of Blastocystis: 
Cystic,  vacuolar,  a  vacuolar,  multivacuolar,  granular  and 
amoeboid form of Blastocystis spp. have been recognized8, 9. 
These  morphologies  have  important  implications  on 
diagnosis, because Blastocystis in faecal samples is generally 
identified by the 10-15 μ in diameter through a large central 
vacuole10. 
Vacuolar and granular forms of Blastocystis:  
The  vacuolar  form  has  been  considered  to  be  the  classic 
Blastocystis  cell  form10.  This  form  is  usually  used  for 
diagnosis  of  Blastocystis,  with  a  range  of  10-50  μm 
diameters,  large  central  body  and  a  rim  of  cytoplasm  and 
nucleus. Granular form of Blastocystis having cytochemically 
and  morphologically  dissimilar  central  vacuole11.  The  cells 
range between an averages of 4 - 15 µm in diameter12. 
Multivacuolar and a vacuolar form of Blastocystis: 
The  multivacuolar  forms  are  approximately  5-8  μ  in 
diameter.  Small  vacuoles  and  one  or  rarely  two  nucleuses 
have been found in the multivacuolar forms12. 
Amoeboid structure of Blastocystis: 
Amoeboid  form  is  a  very  unusual  form  with  irregularly 
shaped  cells  from  2.6  -  7.8  μm  in  diameter  has  extended 
pseudopodia  and  having  one  or  two  nuclei  located  at  the 
middle of the cell13. 
Cyst type of Blastocystis:  
This  form  is  a  solid,  resistive  and  between  3  -  10  μm  in 
diameter14. 
Mitochondrion - like organelles: 
The organelles in Blastocystis similar to mitochondria are a 
mystery like the organism is a strict anaerobe15. 
Life cycles of Blastocystis: 
Blastocystis  inhabits  the  intestinal  tract  of  human  mostly 
caecum  and  colon16.  Binary  fission  is  the  only  method  of 
reproduction for Blastocystis17. 
The cysts forms found in human stools, varies in size from 6 
- 40 μm. Solid-walled cyst present in the faecal samples has 
considered  being  responsible  for  external  transmission,  all 
through  in  the  faecal  -  oral  way  by  means  of  intake  of 
contaminated  food  or  water.  Cysts  transmit  a  disease  into 
epithelial  tissues  of  digestive  region  and  than  multiply 
asexually.  
Vacuolar forms provide source to multi vacuolar or amoeboid 
forms. Then the multi-vacuolar forms convert into a pre-cyst 
form that provide base for a thin-walled cyst, possibly to be 
accountable  for  causing  autoinfection. The  amoeboid  form 
provides  source  to  a  pre-cyst,  which  converts  into  thick-
walled  cyst  through  schizogony. And  than  the  thick-walled 
cyst expelled by faeces18.  
Occurrence of Blastocystis: 
Blastocystis infection is familiar in increasing countries in the 
tropical and subtropical regions11,19 . Infection rate can differ 
from 1.6 % in industrialized countries to more than 50 % in 
different developing countries2, 10. 
Age and sex distribution of Blastocystis: 
Blastocystis infection was more in individuals between 1 - 10 
years  of  age  (46  %)  than in  other  age  group20.  Adults  are 
more infected than children1, 2. Higher prevalence was found 
in adults21 and young adults appear to have the highest rates 
of infection22. Inferior socioeconomic groups and those living 
along with low values of hygiene showed elevated incidence 
rates than the other group of the community23. 
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Figure-1: Life phases of the Blastocystis
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Seasonal pattern of Blastocystis spp:  
The  incidence  of  Blastocystosis  was  more  common  in  hot 
climate24.  Variations  at  different  periods  all  over  the  year 
have not found25. 
Pathogenicity of Blastocystis spp.: 
Human  infections  with  Blastocystis  spp.  are  called 
“Blastocystosis”26 and it present in both asymptomatic  and 
symptomatic individuals. Blastocystis consider as a pathogen, 
when present in 5 per high power magnification field, when 
diagnosed in the absence of other pathogens and amoeboid 
form  indicating  the  pathogenicity  of  this  organism10,  27. 
Blastocystis  causes  different  diseases19,  28.  The  role  of 
Blastocystis like a intestinal pathogen relating to travelers29 
irritable  bowel  syndrome14,    immunosuppressed  patients 
including cancer and HIV / AIDS30,31 hypoalbuminemia and 
anasarca32  acute  and  chronic  urticaria33.  Different 
environmental  factors  like  geography,  seasonal  factors  and 
genetic  diversity  also  associated  with  prevalence  rate, 
pathogenicity, and symptomlogy of Blastocystis infections34, 
35.  B. hominis played a pathogenic position presence with a 
plentiful number in the faecal sample of the patient including 
chronic  myeloid  leukemia  subsequent  bone  marrow 
transplantation36. 
Gastro intestinal symptoms of Blastocystis spp.: 
Symptoms  frequently  distinguished  along  with  Blastocystis 
are  usually  abdominal  pain,  diarrhea  and  nausea37.  
Blastocystis  infection  presents  with  fever,  abdominal  pain 
and  diarrhea38.  Abdominal  pain,  constipation,  diarrhea, 
constipation,  vomiting  and  fatigue  are  the  mainly  common 
symptoms,  while  patients  had  different  underlying  disease 
like  duodenal  ulcer,  leukemia,  ulcerative  colitis,  kidney 
transplant,  peptic  ulcer,  breast  cancer  and  bleeding 
hemorrhoids39. 
Extra intestinal symptoms of Blastocystis spp.:  
Anorexia,  fatigue,  flatulence  and  other  nonspecific 
gastrointestinal effects  also connected with Blastocystosis40 
Itching,  cutaneous  rashes  with  hepatosplenomegaly41, 
eosinophilia42  rectal  bleeding28  and  infection  of  synovial 
fluids43  have  also  been  reported.  Blastocystis  might  be 
responsible for allergic manifestations44. 
Blastocystis in combination with other pathogens: 
G. lamblia was the parasite most commonly identified with 
B. hominis45. B. hominis was present with association with 
other pathogens in 15 cases, while as a sole organism in 81 
samples46.  Blastocystis  was  present  in  21  %  from  56  % 
positive  samples  with  parasites47.  B.  hominis  was  60  %  in 
faecal samples as a single pathogen while associated with E. 
coli  (14  %),  H.  nana  (8  %),  I.  butschlii  (4  %)  and  E. 
histolytica (2 %) 48. 
Blastocystis in Immunocompromised patients: 
High  prevalence  of  72  %  was  reported  in  HIV  /  AIDS 
patients suffering from diarrhea in Indonesia49. The infection 
with Blastocystis was  more common in patients with basic 
chronic-immunosuppressive diseases45. 
Blastocystis in irritable bowel syndrome patients: 
Blastocystosis  has  been  reported  to  be  connected  with 
irritable bowel syndrome (IBS)  50.  Patients with IBS were 
considerably possible to have more then 5 B. hominis / HPF. 
18  %  of  IBS  patients  had  B.  hominis51.  Symptoms  that 
recognized  to  infection  with  Blastocystosis  including 
abdominal pain, diarrhea, cramps and nausea52. Level of IgG 
antibody  of  B.  hominis  present  in  IBS  patients  were  more 
significantly high compared with asymptomatic individuals14. 
Infection of Blastocystis in food handlers: 
B. hominis frequently found in food handlers53, 54. Incidence 
of  B.  hominis  was  8  %  in  symptomatic  and  4  %  in 
asymptomatic food handlers in Egypt55.  E. nana (68 %) was 
the most predominant parasites along with E. coli (36 %), B. 
hominis  (28  %),  E.  histolytica  /  dispar  (10  %)  and  G. 
duodenalis (8 %) were found in food handlers56. 
Blastocystis as a zoonotic infection: 
Zoonosis  is  a  possible  factor  for  rising  prevalence  of 
Blastocystosis. The organism could be zoonotic, since high 
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livestock,  pigs,  birds,  reptiles,  rodents,  amphibians  and 
insects57,  58,  59. 38 % of Blastocystis spp. was found in five 
farms in Brazil60 while, Blastocystis spp. found in 71 % and 
67 % of domestic dogs and cats, respectively in Australia61. 
Prevalence  of  Blastocystis  spp.  is  highly  considered  in  a 
different group of primates, pheasants and ducks58. 
Transmission of Blastocystis: 
Transmission of Blastocystis occurs through the faecal–oral 
route18. Food borne62 and water borne transmission through 
untreated  or  raw  water,  poor  sanitary  conditions  with  low 
environmental  hygiene  are  also  responsible  for 
Blastocystosis63.  Infective cysts could possibly be obtained 
from  contaminated  drinking  water64.  Blastocystis  cysts 
remain  viable  under  suitable  conditions  and  they  could 
survive in chlorinated water at standard concentrations8, 65. 
Diagnosis of Blastocystis: 
Identification  of  the  different  intestinal  parasites  in  stool 
samples  is  the  basic  diagnosis66  and  direct  microscopy  of 
faecal samples without and with concentration method is the 
main  process  of  diagnosis8.  Wet  mount,  trichrome-stained, 
Giemsa  stain10,  Gram  stains67  and  iron  hematoxylins68  are 
also recommended for stool examination for Blastocystosis. 
Formalin  ethyl  concentration  technique  (FECT)  is  more 
considered  to  be  not  sensitive  for  the  diagnosis  of 
Blastocystis8. In vitro cultivation for the intestinal parasites is 
a known established method69. Culture was successful if large 
numbers of Blastocystis were present in the faecal material 
and it is useful when microscopic diagnosis is not sure70 and 
culture method used to confirm the presence of Blastocystis 
because of its specificity and sensitivity71. Blastocystis is a 
firmly  anaerobic  organism  and  grows  in  culture  when 
incubated  at  37oC  an  aerobically.  Pre  reduced  Boeck  and 
Drbohlav's  inspissated  egg  medium72,  Dobell  and  Laidlaw 
medium  covered  with  Ringer  solution  supplemented  along 
with 20 % human serum and streptomycin sulfate, minimal 
essential  medium  having  10  %  horse  serum,  Diamond's 
Trypticase  panmade  serum  (TP-S-1)  monophasic  medium, 
Loffler medium covered with Ringer solution containing 20 
% human serum10 and Iscove's modified Dulbecco's medium 
supplemented  along  with  10  %  horse  serum  also  used  for 
culturing of Blastocystis73. Maintaining continuous cultures is 
time-consuming and costly, and the parasites may be prone to 
genetic drift. Di methyl sulfoxide (DMSO) used commonly 
in  cryopreservation  apply  toxic  effects  on  the  fragile 
Blastocystis isolates74. 
Other diagnostic procedures for Blastocystis: 
Different  techniques  including  aspirated  intestinal  fluid75 
duodenal  aspirate  by  string  test76,  colonic  scrapings  during 
colonoscopy77,  touch  cytology78,  endoscopy  and 
sigmoidoscopy37  detected  B.  hominis  in  the  intestine.  An 
ELISA-based  diagnosis  for  detection  of  Blastocystis  spp. 
from antigens and antibodies has been used for diagnosis of 
the infection in asymptomatic and symptomatic individuals79. 
In  the  indirect  immunofluoresence  test  (IFA),  70  %  of 
individuals were infected with serum positive for detection of 
Blastocystis antibodies80. 
Sub types of Blastocystis: 
Different  sub  types  of  Blastocystis  may  potentially  be  the 
pathogenic  one81.  A  different  number  of  subtypes  can  be 
recognized  in  humans  and  animals  both,  which  indicate  a 
zoonotic potential of these subtypes. Subtype 1 also could be 
observed  in  humans  and  an  extensive  range  of  different 
animals  as  like;  horses,  pigs,  monkeys,  chickens,  cattle, 
rodents, quails, and pheasants82. 
 
Genotypic studies of Blastocystis: 
Blastocystis  has  a  heterogeneous  species83.  Aside  from 
heterogeneity  in  morphology,  Blastocystis  is  antigenically 
and  genetically  dissimilar84.  Genetic  diversity  between  B. 
hominis  and  Blastocystis  spp.  has  been  considered  through 
random amplified polymorphic DNA (RAPD) and restriction 
fragment length polymorphism (RFLP) examination of PCR-
amplified small – sub unit (SSU) r RNA57. 
Treatment of Blastocystosis: 
Treatment  of  Blastocystis  infections  is  necessary  when 
symptoms are present and no any other cause of disease is 
understandable10.  Emetine,  Furazolidone, 
Iodochlorhydroxyquin,  Metronidazole,  Pentamidine  and 
Trimethoprim-Sulfamethoxazole  (TMP  -  SMX)  were 
observed to be the mainly antimicrobial agents in opposition 
to  B.  hominis85.Commonly  recommended  drug  is 
Metronidazole for treatment with a dosage of 250 -750 mg 3 
days, or 2 g per day for five days2. Co-Trimoxazole had a 
very good effect on the cure rate without side effects for the 
treatment of Blastocystosis86. Nitazoxanide had  much  more 
positive  effects  with  effectively  cured87.  Treatment  with 
Rifaximin was effective in solving the clinical symptoms and 
clearing  B.  hominis  infections  connected  with 
enteropathogenic bacteria in HIV-1 infected patients88.  
Prevention and Control of Blastocystosis:  
B.  hominis  is transmitted  by  the  faecal-oral  by  unhygienic 
food  and  water,  and  the  cyst  form  is  the  infective  part  of 
transmission89. Control measures on the person level are good 
quality  individual  hygiene,  community  sanitary  facilities, 
instruction  to  keep  away  from  faecal  contamination  of  the 
surroundings  and  ingestion  of  contaminated  material. 
Biochemistry  information  of  the  organism  is  still 
undeveloped;  the  specific  metabolic  sites  with  drugs  could 
not  be  satisfactorily  targeted.  The  CDC  has  the  some 
following  instructions,  though  as  potentially  useful 
preventative and control measures. Hand hygienic with soap 
and water before usage food and after using the toilet.  Stay 
away from infected water and food. Wash and peel the entire 
raw fruits and vegetables. Avoid raw tap water and half or 
uncooked foods during travelling. Clean hands properly with 
soap and water after changing the children’s diapers.   
 
CONCLUSION 
Blastocystis hominis, a potential diarrheal agent particularly 
cause  serious  infection  in  children  of  low  socio-economic 
status and attacks those who have impaired immune system 
or  a  much  weakened  digestive  tract.  Its  prevalence  is 
more where there is no paid attention by authorities regarding 
hygienic measures, as the major mode of transmission is fecal 
oral route. Keeping into consideration, there is a dire need to 
create health awareness and to maintain hygienic standards in 
terms of sanitation promote hand washing with soap before 
having meal and using toilet, avoid potentially infected food 
and water. 
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